Alkermes (ALKS) Shares Outstanding (Entity) (2010 - 2026)
Alkermes (ALKS) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.27 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | 183.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183.59 Mn |
| Dec 31, 2025 | 181.01 Mn |
| Sep 30, 2025 | 180.50 Mn |
| Jun 30, 2025 | 180.44 Mn |
| Mar 31, 2025 | 180.18 Mn |
| Dec 31, 2024 | 176.67 Mn |
| Sep 30, 2024 | 176.26 Mn |
| Jun 30, 2024 | 175.96 Mn |
| Mar 31, 2024 | 175.73 Mn |
| Dec 31, 2023 | 172.57 Mn |
| Sep 30, 2023 | 172.22 Mn |
| Jun 30, 2023 | 171.98 Mn |
| Mar 31, 2023 | 171.52 Mn |
| Dec 31, 2022 | 168.95 Mn |
| Sep 30, 2022 | 168.86 Mn |
| Jun 30, 2022 | 168.78 Mn |
| Mar 31, 2022 | 167.74 Mn |
| Dec 31, 2021 | 165.79 Mn |
| Sep 30, 2021 | 165.44 Mn |
| Jun 30, 2021 | 164.97 Mn |